MANNING PAUL B purchased 24.9% of their position (550.46K shares) of CANDEL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $3.00M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/26/2026ACC: 0001193125-26-078246
+550.46K
Net shares
Net buyer
$3.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
550.46K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+550.46K
Price / share
$5.45
Trade value
$3M
% of position
24.9%
2/23/2026
2.21M→2.76M
Total
Net shares
+550.46K
Net value
$3M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/23/2026 | P · Purchase | +550.46K | $5.45 | $3M | 24.9% | 2.21M | 2.76M |
| Total | +550.46K | $3M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned1.68M
Common Stock
IndirectShares owned1.30M
Total
1.68M direct·1.30M indirect2.98M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.68M | Direct |
| Common Stock | 1.30M | Indirect |
| Total | 2.98M | 1.68M direct·1.30M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported